Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Hakan Parlakpinar & Mehmet Gunata. (2021) Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs. Immunopharmacology and Immunotoxicology 43:6, pages 651-665.
Read now
Read now
Daniel R. Getts, Meghann T. Getts, Derrick P. McCarthy, Emily ML Chastain & Stephen D. Miller. (2010) Have we overestimated the benefit of human(ized) antibodies?. mAbs 2:6, pages 682-694.
Read now
Read now
Ronald F Parsons, Kumar Vivek, Robert R Redfield, Thi-Sau Migone, Michael P Cancro, Ali Naji & Hooman Noorchashm. (2009) B-cell tolerance in transplantation: is repertoire remodeling the answer?. Expert Review of Clinical Immunology 5:6, pages 703-723.
Read now
Read now
C Bracewell, JD Isaacs, P Emery & WF Ng. (2009) Atacicept, a novel B cell-targeting biological therapy for the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 9:7, pages 909-919.
Read now
Read now
S Lewis Cox & Pablo A Silveira. (2009) Emerging roles for B lymphocytes in Type 1 diabetes. Expert Review of Clinical Immunology 5:3, pages 311-324.
Read now
Read now
Articles from other publishers (37)
Hamideh Raeisi, Masoumeh Azimirad, Ali Nabavi-Rad, Hamid Asadzadeh Aghdaei, Abbas Yadegar & Mohammad Reza Zali. (2022) Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective. Frontiers in Immunology 13.
Crossref
Crossref
Srikanth Mukkera, Maneesh Mannem, Karthik Chamarti, Leela Pillarisetty, Sai Swarupa Vulasala, Lakshmi Alahari, Anusha Ammu, Akshathh Mukkera & Rajeev K Vadlapatla. (2022) Systemic Lupus Erythematosus-Associated Serositis Managed With Intravenous Belimumab: A Case Report. Cureus.
Crossref
Crossref
Marvin J. Fritzler & Michael Mahler. 2021. Precision Medicine and Artificial Intelligence. Precision Medicine and Artificial Intelligence
39
63
.
Ruei-Min Lu, Yu-Chyi Hwang, I-Ju Liu, Chi-Chiu Lee, Han-Zen Tsai, Hsin-Jung Li & Han-Chung Wu. (2020) Development of therapeutic antibodies for the treatment of diseases. Journal of Biomedical Science 27:1.
Crossref
Crossref
Sandra A. Morais, Andreia Vilas-Boas & David A. Isenberg. (2015) B-cell survival factors in autoimmune rheumatic disorders. Therapeutic Advances in Musculoskeletal Disease 7:4, pages 122-151.
Crossref
Crossref
Ignasi Rodriguez-Pintó, Gerard Espinosa & Ricard Cervera. (2015) Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus. Clinical Investigation 5:6, pages 561-571.
Crossref
Crossref
Fabienne Niederer, Almut Scherer, Diego Kyburz, Renate E. Gay, Steffen Gay, Beat A. Michel & Adrian Ciurea. (2013) Taux sériques de BAFF chez les patients atteints de spondylarthrite ankylosante et traités par anti-TNF. Revue du Rhumatisme 80:4, pages 417-419.
Crossref
Crossref
Fabienne Niederer, Almut Scherer, Diego Kyburz, Renate E. Gay, Steffen Gay, Beat A. Michel & Adrian Ciurea. (2013) BAFF levels in patients with ankylosing spondylitis and response to anti-tumor necrosis factor treatment. Joint Bone Spine 80:4, pages 433-434.
Crossref
Crossref
A. España, E. Ornilla & C. Panizo. (2013) Rituximab in dermatology. Actas Dermo-Sifiliográficas (English Edition) 104:5, pages 380-392.
Crossref
Crossref
A. España, E. Ornilla & C. Panizo. (2013) Rituximab en dermatología. Actas Dermo-Sifiliográficas 104:5, pages 380-392.
Crossref
Crossref
A. Arazi & A.U. Neumann. (2013) The role of positive feedback loops involving anti-dsDNA and anti–anti-dsDNA antibodies in autoimmune glomerulonephritis. Journal of Theoretical Biology 319, pages 8-22.
Crossref
Crossref
Yehunda Shoenfeld, Pier Luigi Meroni & Ricard CerveraRicard CerveraGerard Espinosa. 2012. Immunotherapeutic Agents for SLE. Immunotherapeutic Agents for SLE
42
54
.
Ricard Cervera & Gerard Espinosa. (2011) Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus. Clinical Investigation 1:11, pages 1555-1561.
Crossref
Crossref
Changhai Ding, Ran Li, Jianhua Xu, Flavia Cicuttini & Graeme Jones. (2011) Belimumab therapy for systemic lupus erythematosus and potential treatment of rheumatoid arthritis. Drug Development Research 72:7, pages 623-633.
Crossref
Crossref
S. Audia, B. Lorcerie, B. Godeau & B. Bonnotte. (2011) Physiopathologie du purpura thrombopénique immunologique. La Revue de Médecine Interne 32:6, pages 350-357.
Crossref
Crossref
Yunjie Liu, Lingling Zhang, Yingqi Wu, Tong Tong, Wendi Zhao, Peipei Li, Min Huang, Wenxiang Wang, Jianmin Fang & Wei Wei. (2011) Therapeutic effects of TACI-Ig on collagen-induced arthritis by regulating T and B lymphocytes function in DBA/1 mice. European Journal of Pharmacology 654:3, pages 304-314.
Crossref
Crossref
Norman T. Ilowite & Ronald M. Laxer. 2011. Textbook of Pediatric Rheumatology. Textbook of Pediatric Rheumatology
71
126
.
Gerlinde Obermoser, Karolina Palucka, Hideki Ueno, Jacques Banchereau & Virginia Pascual. 2011. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
115
127
.
Yrjö T. Konttinen, Alberto Vivó Porcar, Pauliina Porola, Katja Koskenpato, María Lorés Rodriguez, Raimo Pöllänen, Vasily Stegaev, Liisa Virkki, Michelle Spaan & Beata D. Przybyla. 2012. Sjögren’s Syndrome. Sjögren’s Syndrome
151
175
.
A. Arazi & A.U. Neumann. (2010) Modeling immune complex-mediated autoimmune inflammation. Journal of Theoretical Biology 267:3, pages 426-436.
Crossref
Crossref
Ronald F. Parsons, Kumar Vivek, Robert R. RedfieldIIIIII, Thi-Sau Migone, Michael P. Cancro, Ali Naji & Hooman Noorchashm. (2010) B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation. Transplantation Reviews 24:4, pages 207-221.
Crossref
Crossref
H. L. Wright, R. J. Moots, R. C. Bucknall & S. W. Edwards. (2010) Neutrophil function in inflammation and inflammatory diseases. Rheumatology 49:9, pages 1618-1631.
Crossref
Crossref
Patrizia Scapini, Yongmei Hu, Ching-Liang Chu, Thi-Sau Migone, Anthony L. DeFranco, Marco A. Cassatella & Clifford A. Lowell. (2010) Myeloid cells, BAFF, and IFN-γ establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. Journal of Experimental Medicine 207:8, pages 1757-1773.
Crossref
Crossref
Anna Bazsó, Gyula Poór, Péter Gergely & Emese Kiss. (2010) Novel therapeutic possibilities in systemic lupus erythematosus. Orvosi Hetilap 151:18, pages 735-740.
Crossref
Crossref
Susan Lee & Mark Ballow. (2010) Monoclonal antibodies and fusion proteins and their complications: Targeting B cells in autoimmune diseases. Journal of Allergy and Clinical Immunology 125:4, pages 814-820.
Crossref
Crossref
Ge Wu. 2010. Assay Development. Assay Development
1
25
.
Virginia PascualDamien ChaussabelJacques Banchereau. (2010) A Genomic Approach to Human Autoimmune Diseases. Annual Review of Immunology 28:1, pages 535-571.
Crossref
Crossref
Lisa S Jeffs, Plinio R Hurtado, Randall J Faull & Chen Au Peh. (2010) Antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement. International Journal of Evidence-Based Healthcare 8:1, pages 18-27.
Crossref
Crossref
A. Hansen & T. Dörner. (2009) Aktuelle therapeutische Optionen bei Sjögren-SyndromCurrent therapeutic options in Sjögren’s syndrome. Zeitschrift für Rheumatologie 69:1, pages 19-24.
Crossref
Crossref
Claudio Ponticelli & Gabriella Moroni. (2010) Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE). Pharmaceuticals 3:1, pages 300-322.
Crossref
Crossref
M. Fabris, F. Grimaldi, D. Villalta, A. Picierno, C. Fabro, M. Bolzan, S. De Vita & E. Tonutti. (2010) BLyS and April serum levels in patients with autoimmune thyroid diseases. Autoimmunity Reviews 9:3, pages 165-169.
Crossref
Crossref
Rizgar A. Mageed, Taher E. Taher & Ali S. Jawad. 2010. Gene Therapy for Autoimmune and Inflammatory Diseases. Gene Therapy for Autoimmune and Inflammatory Diseases
127
146
.
Diana J. Auyeung-Kim, Madhav N. Devalaraja, Thi-Sau Migone, Wendy Cai & Gary J. Chellman. (2009) Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator. Reproductive Toxicology 28:4, pages 443-455.
Crossref
Crossref
Andras Perl. (2009) Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome. Current Opinion in Rheumatology 21:5, pages 443-447.
Crossref
Crossref
A. Illes, L. Varoczy, G. Papp, P. C. Wilson, P. Alex, R. Jonsson, T. Kovacs, Y. T. Konttinen, M. Zeher, B. Nakken & P. Szodoray. (2009) Aspects of B-Cell Non-Hodgkin’s Lymphoma Development: A Transition from Immune-Reactivity to Malignancy. Scandinavian Journal of Immunology 69:5, pages 387-400.
Crossref
Crossref
Capucine Daridon, Gerd R Burmester & Thomas Dörner. (2009) Anticytokine therapy impacting on B cells in autoimmune diseases. Current Opinion in Rheumatology 21:3, pages 205-210.
Crossref
Crossref
Lalit Pallan, Caroline O. Savage & Lorraine Harper. (2009) ANCA-associated vasculitis: from bench research to novel treatments. Nature Reviews Nephrology 5:5, pages 278-286.
Crossref
Crossref